Apta Biosciences Ltd
Apta Biosciences is bringing to market a pipeline of game changing healthcare products (the first to be launched in 2017) using its highly proprietary third generation affinity molecules that can be broadly applied to diagnostics and therapeutics.
Apta is led by a team experienced in building life science companies from early stage to exit, a team that have realized billions $ of value for investors.
The choice you make above will help our platform display content that is best suited to you
Welcome to the new Wholesale Investor platform. Please use your existing log in details to access the site. Alternatively feel free to use the "Login with LinkedIn" or "Sign in with Google" buttons.
Enter your email to reset your password.